bioAffinity Technologies, Inc. Cash Flow Statement

Cash Flow Statement Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -6.33M-8.15M-7.94M-9.04M
Depreciation and Depletion 0.01M0.23M0.16M
Share-based Compensation 43.01M0.25M0.75M0.99M
Gains from Sales and Divestitures 0.03M0.06M0.03M
Gains from Investment Securities 4.08M0.01M0.09M0.36M
Non-cash Items 0.16M0.16M
Cash from Operations -2.05M-4.07M-6.04M-7.26M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.48M2.06M
Depreciation & Amortization (CF) 0.00M0.01M0.25M0.61M
Change in Working Capital
Change in Receivables 0.01M-0.31M0.33M
Change in Inventory 0.01M0.01M0.01M
Change in Account Payables 0.04M0.11M-0.01M0.38M
Change in Accured Expenses 0.52M0.44M0.36M0.25M
Other Working Capital Changes 0.03M0.49M-0.21M0.11M
Investing Activities
Capital Expenditures 0.22M0.02M0.08M
Acquisitions 2.19M
Cash from Investing Activities -0.22M-2.21M-0.08M
Financing Activities
Other financing activities 0.18M0.25M0.75M0.99M
Cash from Financing Activities 3.33M14.34M-0.34M5.63M
Additional items
Change in Cash 1.28M10.05M-8.59M-1.72M
Beginning Cash Balance -1.28M1.36M11.41M2.82M
Free Cash Flow -2.05M-4.29M-6.06M-7.34M
Net Cash Flow 1.28M10.05M-8.59M-1.72M